Почетна › Рак на бели дробови со не-мали клетки › Њу Џерси › Edison
Клинички испитувања за Рак на бели дробови со не-мали клетки во Edison, NJ
47 студии за Рак на бели дробови со не-мали клетки бараат учесници на локации во и околу Edison (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Се регрутираФаза 1
- START New Jersey, East Brunswick · на 6 милји
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Се регрутираФаза 1
- Exelixis Clinical Site #88, East Brunswick · на 6 милји
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Се регрутираФаза 2/3
- Astera Cancer Care /ID# 277570, East Brunswick · на 6 милји
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Се регрутираФаза 2
- START New Jersey, East Brunswick · на 6 милји
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Се регрутираФаза 1
- Research Site, New Brunswick · на 3 милји
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Се регрутираФаза 1/2
- Astera Cancer Care /ID# 271915, East Brunswick · на 6 милји
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Се регрутираФаза 2/3
- Astera Cancer Care, East Brunswick · на 6 милји
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Astera Cancer Care /ID# 272359, East Brunswick · на 6 милји
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Се регрутираФаза 1/2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
Се регрутираФаза 3
- Clinical Study Site, New Brunswick · на 3 милји
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Се регрутираФаза 3
- Astera Cancer Care, Edison
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Се регрутираФаза 1
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Се регрутираФаза 2/3
- Local Institution - 007-975-A, Somerset · на 4 милји
- Local Institution - 007-975-B, Somerset · на 4 милји
- Local Institution - 007-975-C, Somerset · на 4 милји
- и уште 2
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Using Urine Samples to Identify Lung Cancer
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Се регрутираФаза 1/2
- START New Jersey East Brunswick, East Brunswick · на 6 милји
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Се регрутираНабљудувачка студија
- Astera Cancer Care, East Brunswick · на 6 милји
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Се регрутираФаза 1
- Site 104 - START New Jersey, East Brunswick · на 6 милји
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Се регрутираФаза 1
- Rutgers Cancer Institute, New Brunswick · на 3 милји
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Се регрутира
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Се регрутираФаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Се регрутираФаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
Се регрутираФаза 2
- Astera Cancer Care, East Brunswick · на 6 милји
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Се регрутираФаза 3
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Се регрутираФаза 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Се регрутираНабљудувачка студија
- Memorial Sloan Kettering Basking Ridge (Consent Only), Basking Ridge · на 15 милји
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
Се регрутираФаза 1
- START Astera, LLC, East Brunswick · на 6 милји
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Се регрутираФаза 1
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Virtua Voorhees, Voorhees Township · на 5 милји
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Се регрутираФаза 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Се регрутираФаза 2
- Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Virtua Voorhees, Voorhees Township · на 5 милји
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2
- Virtua Voorhees, Voorhees Township · на 5 милји
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
Се регрутираФаза 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · на 3 милји
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Се регрутираФаза 2/3
- Virtua Voorhees, Voorhees Township · на 5 милји
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Се регрутираФаза 1/2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · на 15 милји
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · на 15 милји
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Се регрутираФаза 2
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · на 15 милји
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Се регрутираФаза 1/2
- START, Astera, East Brunswick · на 6 милји
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, New Brunswick · на 3 милји
Испитувања за Рак на бели дробови со не-мали клетки во други градови
- Houston, TX145 студии
- New York City, NY120 студии
- Arlington, VA104 студии
- Nashville, TN97 студии
- Boston, MA90 студии
- Los Angeles, CA87 студии
- St. Louis, MO73 студии
- Chicago, IL61 студија
- Baltimore, MD60 студии
- San Antonio, TX59 студии
- Columbus, OH56 студии
- Washington, DC55 студии
Други студии во Edison
- Рак на дојка68 студии
- Рак (сите типови)33 студии
- Рак на простата29 студии
- Колоректален карцином23 студии
- Рак на бели дробови23 студии
- Множен миелом22 студии
- Рак на бешиката21 студија
- Метастатски карцином20 студии
- Карцином на јајниците20 студии
- Акутна миелоидна леукемија20 студии
- Рак на ендометриумот19 студии
- Уротелен (транзицисно клеточен) карцином18 студии
Од ClinicalTrials.gov, податоци преземени 5.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.